Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q55891386)
Watch
English
Antiphospholipid syndrome
scientific article published in The Lancet
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20822807
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20822807%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 February 2020
title
Antiphospholipid syndrome
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20822807
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20822807%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 February 2020
author
Guillermo Ruiz-Irastorza
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20822807
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20822807%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 February 2020
Munther A. Khamashta
series ordinal
4
object named as
Munther A Khamashta
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20822807
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20822807%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 February 2020
David Branch
series ordinal
3
object named as
Ware Branch
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20822807
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20822807%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 February 2020
author name string
Mark Crowther
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20822807
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20822807%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 February 2020
language of work or name
English
0 references
publication date
6 September 2010
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20822807
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20822807%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 February 2020
published in
The Lancet
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20822807
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20822807%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 February 2020
volume
376
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20822807
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20822807%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 February 2020
issue
9751
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20822807
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20822807%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 February 2020
page(s)
1498-1509
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20822807
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20822807%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 February 2020
cites work
The antiphospholipid syndrome: ten years on.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The antiphospholipid syndrome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Proteomic analysis in monocytes of antiphospholipid syndrome patients: deregulation of proteins related to the development of thrombosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
In vivo effects of an inhibitor of nuclear factor-kappa B on thrombogenic properties of antiphospholipid antibodies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pathophysiology of the antiphospholipid syndrome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Placentation, antiphospholipid syndrome and pregnancy outcome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pathogenic role of anti-beta 2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of beta 2-glycoprotein I binding to trophoblast cells and functional effects of anti-beta 2-glycoprotein I antibodies in vitro
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antiphospholipid antibodies induce a pro-inflammatory response in first trimester trophoblast via the TLR4/MyD88 pathway
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Incidence and risk factors of thromboembolism in systemic lupus erythematosus: a comparison of three ethnic groups
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High Impact of Antiphospholipid Syndrome on Irreversible Organ Damage and Survival of Patients With Systemic Lupus Erythematosus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Diagnostic testing for coagulopathies in patients with ischemic stroke
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Thrombophilia testing in patients with venous thromboembolism. Findings from the RIETE registry.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Recurrent miscarriage
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antiphospholipid antibodies and beta 2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Fetal death
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
First-trimester placentation and the risk of antepartum stillbirth
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antiphospholipid antibodies and fetal death
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The preterm prediction study: Risk factors for indicated preterm births
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Central nervous system involvement in the antiphospholipid (Hughes) syndrome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vasculitis, antiphospholipid antibodies, and renal artery stenosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Elevated antiphospholipid antibody titers and adverse pregnancy outcomes: analysis of a population-based hospital dataset
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Revision of the Sapporo criteria for the antiphospholipid syndrome-- coming to grips with evidence and Thomas Bayes?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A prospective study of antibodies to beta2-glycoprotein I and prothrombin, and risk of thrombosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antibody profiles for the diagnosis of antiphospholipid syndrome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Laboratory and clinical features of pregnant women with antiphospholipid syndrome and neonatal outcome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical course of high-risk patients diagnosed with antiphospholipid syndrome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
How we diagnose the antiphospholipid syndrome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
How I treat the antiphospholipid syndrome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Management of antiphospholipid antibody syndrome: a systematic review
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
How we diagnose and treat thrombotic manifestations of the antiphospholipid syndrome: a case-based review
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognostic factors and clustering of serious clinical outcomes in antiphospholipid syndrome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
[Factors related to the risk of thrombosis in patients with lupus and antiphospholipid antibodies]
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Recurrent miscarriage and long-term thrombosis risk: a case-control study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Influence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: do the benefits outweigh the risks? A decision analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Catastrophic antiphospholipid syndrome (CAPS): update from the 'CAPS Registry'.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lupus and pregnancy: ten questions and some answers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and/or the antiphospholipid syndrome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: a multivariate analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pregnancy outcome in recurrent spontaneous abortion associated with antiphospholipid antibodies: a comparative study of intravenous immunoglobulin versus prednisone plus low-dose aspirin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Obstetric outcome in antiphospholipid syndrome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical study and follow-up of 100 patients with the antiphospholipid syndrome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anti-inflammatory and immunosuppressive drugs and reproduction
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antiaggregant and anticoagulant therapy in systemic lupus erythematosus and Hughes' syndrome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of clopidogrel added to aspirin in patients with atrial fibrillation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
New antithrombotic drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dabigatran versus warfarin in patients with atrial fibrillation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dabigatran versus warfarin in the treatment of acute venous thromboembolism
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A systematic review of the off-label use of biological therapies in systemic autoimmune diseases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
New treatment option for the antiphospholipid antibody syndrome? More pleiotropic effects of the statin drugs.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibition of the thrombogenic and inflammatory properties of antiphospholipid antibodies by fluvastatin in an in vivo animal model
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Fluvastatin inhibits up-regulation of tissue factor expression by antiphospholipid antibodies on endothelial cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Statins for the treatment of antiphospholipid syndrome?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized trial of rosuvastatin in the prevention of venous thromboembolism
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hydroxychloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960709-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0140-6736(10)60709-X
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20822807
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20822807%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 February 2020
PubMed publication ID
20822807
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20822807
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20822807%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 February 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit